AJP - GI Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (October 20, 2005). doi:10.1152/ajpgi.00167.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/2/G335    most recent
00167.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jaiswal, K.
Right arrow Articles by Sarosi, Jr., G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jaiswal, K.
Right arrow Articles by Sarosi, Jr., G. A.
Submitted on April 13, 2005
Accepted on October 15, 2005

Bile Salt Exposure Increases Proliferation Through p38 and ERK-MAPK Pathways in a Non-Neoplastic Barrett's Cell Line

Kshama Jaiswal1, Christie Lopez-Guzman1, Rhonda F. Souza1, Stuart J. Spechler1, and George A. Sarosi, Jr.1*

1 Department of Surgery, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA; Department of Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA; Gastroenterology, University of Texas Health Center, Dallas, TX, USA

* To whom correspondence should be addressed. E-mail: George.Sarosi{at}utsouthwestern.edu.

Introduction: Bile reflux has been implicated in the neoplastic progression of Barrett's esophagus (BE). Bile salts increase proliferation in a Barrett's-associated adenocarcinoma cell line (SEG-1) by activating ERK and p38- MAPK pathways. However, it is not clear that these findings in cancer cells are applicable to the non-neoplastic cells of benign Barrett's esophagus. We examined the effect of bile salts on three human cell lines: normal esophageal squamous (NES), non-neoplastic Barrett's cells (BAR), and a Barrett's derived adenocarcinoma cell line, SEG-1. We hypothesized that bile salt exposure activates pro-proliferative and anti-apoptotic pathways to promote increased growth in BE. Methods: NES, BAR, and SEG-1 cells were exposed to glycochenodeoxycholic acid (GCDA) at a neutral pH for 5 minutes. Proliferation was measured by Coulter counter cell counts and BrdU incorporation assay. GCDA-induced MAPK activation was examined by Western blot for phosphorylated ERK and p38. Apoptosis was measured by TUNEL and Annexin-V staining after GCDA and UV-B exposure. Statistical significance was determined by ANOVA. Results: NES cells exposed to 5 minutes of GCDA did not increase cell number. In BAR cells, GCDA exposure increased cell number by 31%, increased phosphorylated p38 and ERK levels by 2-3 fold, increased BrdU incorporation by 30%, and decreased UV-induced apoptosis by 15-20%. Conclusion: In a non-neoplastic Barrett's cell line, GCDA exposure induces proliferation by activation of both the ERK and p38 MAPK pathways. These findings suggest a potential mechanism whereby bile reflux may facilitate the neoplastic progression of Barrett's esophagus.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.